Cargando…
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial
BACKGROUND AND PURPOSE: Rapid genotyping is useful for guiding early antiplatelet therapy in patients with high-risk nondisabling ischaemic cerebrovascular events (HR-NICE). Conventional genetic testing methods used in CYP2C19 genotype-guided antiplatelet therapy for patients with HR-NICE did not sa...
Autores principales: | Meng, Xia, Wang, Anxin, Zhang, Guojun, Niu, Siying, Li, Wei, Han, Sifei, Fang, Fang, Zhao, Xingquan, Dong, Kehui, Jin, Zening, Zheng, Huaguang, Chen, Kelin, Li, Hao, Yang, Chengyuan, Wang, Yongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258065/ https://www.ncbi.nlm.nih.gov/pubmed/33952669 http://dx.doi.org/10.1136/svn-2021-000874 |
Ejemplares similares
-
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
por: Wang, Yongjun, et al.
Publicado: (2021) -
The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study
por: Yang, Yuling, et al.
Publicado: (2016) -
Factors for short-term outcomes in patients with a minor stroke: results from China National Stroke Registry
por: Wu, Lingyun, et al.
Publicado: (2015) -
Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
por: Wang, David, et al.
Publicado: (2016) -
In-hospital medical complications associated with stroke recurrence after initial ischemic stroke: A prospective cohort study from the China National Stroke Registry
por: Wang, Penglian, et al.
Publicado: (2016)